Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC
Clinical trial NCT06081673 · RECRUITING
Trial details
- NCT number
- NCT06081673
- Sponsor
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-30
- Primary completion
- 2024-12-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.